Aureka
PrivateLast Round
Series A
Extension
Apr 28, 2026
Total Funding Raised
$100M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Aureka Biotechnologies is a biotechnology company that develops a therapeutic discovery platform using generative AI and high-throughput screening to design and discover antibody therapeutics.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Medical AI, ML Platforms
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Aureka Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
Aureka Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A Extension | Apr 28, 2026 | ||||
| Series A | Nov 10, 2025 | ||||
| Seed | Mar 1, 2024 |
Aureka Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| BioTrack Capital | Series A Extension |
| HongShan | Series A Extension |
| 5Y Capital | Series A Extension, Series A |
| NRL Capital | Series A Extension, Series A, Seed |
| 险峰K2VC | Seed |
| Qiming Venture Partners | Series A Extension, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 28, 2026
Raised $35M led by HongShan (红杉中国)
- Jan 29, 2026
Monthly visitors increased 568% MoM.
Aureka Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Aureka's valuation, stock price, and market status.